Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-184-4 | CAS number: 38900-29-7
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
- Value:
- 0.046 mg/cm²
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 5
- AF for intraspecies differences:
- 5
- Justification:
- Standard worker assessment factor
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The substances in the category are considered to be similar on the basis that they have common structures of a lithium ion varying only by the length of the fatty acid chain. As a result, it is expected that the substances will have similar, predictable properties. REACH Annex V, Entry 9, groups fatty acids and their potassium, sodium, calcium and magnesium salts, including C6 to C24, predominantly even-numbered, unbranched, saturated or unsaturated aliphatic monocarboxylic acids. Since published reviews do not distinguish between the properties of monocarboxylic or dicarboxylic acids as a category, then the same interpretation can be applied to the dicarboxylic acids. Due to the close structural similarity and the narrow range of carbon chain numbers covered in this category, the toxicity expected to be similar across the category.
None of the category substances have been tested by the inhalation route. The lithium salts of dicarboxylic salts C6 - C10 have vapour pressures of <1.3 x 10(-8) Pa at 20°C and are exclusively manufactured in situ in base oil and not in isolated form, so the potential for the generation of inhalable forms is low. Also, the use of the grease forms will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be unlikely to occur.
Acute oral toxicity studies in rats conducted on lithium salts of dicarboxylic acids C6-C10 showed consistent evidence of acute toxicity, with a discriminating dose of 300 mg/kg bw. An acute dermal toxicity studies in rats conducted on dilithium adipate and dilithium sebacate, showed a lack of acute toxicity up to the highest dose tested (2000 mg/kg bw or greater).
A combined short-term repeat dose and reproductive toxicity screening study via dermal route was conducted on fatty acids C18 -(unsaturated) lithium salts. No systemic effects were observed at the highest dose tested so the NOAEL was determined to be 1089.75 mg/kg bw/day. However, as there is no clear evidence of rate and level uptake of the substance to allow the potential for systemic toxicity, it is proposed not to use this study to calculate DNELs. Instead, it is proposed to conduct route to route extrapolation in order to calculate DNELs based results of the ongoing OECD 422 study via oral route on dilithium adipate. It is proposed that the acute/short-term DNEL is extrapolated from the long-term DNEL when available.
The experimental results from the repeated dose dermal toxicity study on fatty acids C18 (unsaturated) lithium did permit consideration of long-term local effects on the skin. The NOAEL for this effect was 111.25 mg/kg/day, which converts to 0.23 mg/cm2dilithium adipate based on lithium ion concentration and on the area of rat skin exposed in the subacute study (average weight of the rats in the study was 311 g, the body surface area was calculated as being approximately 9.1 x bw(g)0.66, and the approximate surface area exposed was 10%).
Available data show that all the substances in the category of lithium salts of C6-C10 dicarboxylic acids exhibit a similar lack of irritant and corrosive properties requiring classification.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.023 mg/cm²
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 10
- AF for intraspecies differences:
- 10
- Justification:
- Standard general population assessment factor
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- insufficient hazard data available (further information necessary)
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The substances in the category are considered to be similar on the basis that they have common structures of a lithium ion varying only by the length of the fatty acid chain. As a result, it is expected that the substances will have similar, predictable properties. REACH Annex V, Entry 9, groups fatty acids and their potassium, sodium, calcium and magnesium salts, including C6 to C24, predominantly even-numbered, unbranched, saturated or unsaturated aliphatic monocarboxylic acids. Since published reviews do not distinguish between the properties of monocarboxylic or dicarboxylic acids as a category, then the same interpretation can be applied to the dicarboxylic acids. Due to the close structural similarity and the narrow range of carbon chain numbers covered in this category, the repeated dose toxicity expected to be similar across the category.
The lithium salts of dicarboxylic salts C6 - C10 have vapour pressures of <1.3 x 10(-8) Pa at 20°C and are exclusively manufactured in situ in base oil and not in isolated form, so the potential for the generation of inhalable forms is low. The general population are only exposed to the substance as part of the formulated greases, which are viscous liquids. The use of the grease forms will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be unlikely to occur.
Acute oral toxicity studies in rats conducted on lithium salts of dicarboxylic acids C6-C10 showed consistent evidence of acute toxicity, with a discriminating dose of 300 mg/kg bw. An acute dermal toxicity studies in rats conducted on dilithium adipate and dilithium sebacate, showed a lack of acute toxicity up to the highest dose tested (2000 mg/kg bw or greater).
A combined short-term repeat dose and reproductive toxicity screening study via dermal route was conducted on fatty acids C18 -(unsaturated) lithium salts. No systemic effects were observed at the highest dose tested so the NOAEL was determined to be 1089.75 mg/kg bw/day. However, as there is no clear evidence of rate and level uptake of the substance to allow the potential for systemic toxicity, it is proposed not to use this study to calculate DNELs. Instead, it is proposed to conduct route to route extrapolation in order to calculate DNELs based results of the ongoing OECD 422 study via oral route on dilithium adipate. It is proposed that the acute/short-term DNEL is extrapolated from the long-term DNEL when available.
The experimental results from the repeated dose dermal toxicity study on fatty acids C18 (unsaturated) lithium did permit consideration of long-term local effects on the skin. The NOAEL for this effect was 111.25 mg/kg/day, which converts to 0.23 mg/cm2 dilithium adipate based on lithium ion concentration and on the area of rat skin exposed in the subacute study (average weight of the rats in the study was 311 g, the body surface area was calculated as being approximately 9.1 x bw(g)0.66, and the approximate surface area exposed was 10%).
Available data show that all the substances in the category of lithium salts of C6-C10 dicarboxylic acids exhibit a similar lack of irritant and corrosive properties requiring classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
